Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing

被引：0
|
作者：
Malcolmson, James
Hughes, Rebecca
Husselbury, Tim
Khan, Kamran
Learoyd, Annastazia E.
Lees, Martin
Wicks, Eleanor
Smith, Jamie
Simms, Alexander
Moon, James
Lopes, Luis
O'Mahony, Constantinos
Sekhri, Neha
Elliott, Perry M.
Petersen, Steffen E.
Dhinoja, Mehul B.
Mohiddin, Saidi A.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Hypertrophic cardiomyopathy; Pacemakers;
D O I：
10.1161/circ.148.suppl_1.17689Circulation
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A17689
引用
收藏
页数：3
相关论文
共 32 条
  • [1] Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing
    Malcolmson, James W.
    Hughes, Rebecca K.
    Husselbury, Tim
    Khan, Kamran
    Learoyd, Annastazia E.
    Lees, Martin
    Wicks, Eleanor C.
    Smith, Jamie
    Simms, Alexander D.
    Moon, James C.
    Lopes, Luis R.
    O'Mahony, Constantinos
    Sekhri, Neha
    Elliott, Perry M.
    Petersen, Steffen E.
    Dhinoja, Mehul B.
    Mohiddin, Saidi A.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2024, 17 (07):
  • [2] Therapeutic benefits of distal ventricular pacing in mid-cavity obstructive hypertrophic cardiomyopathy
    Malcolmson, James W.
    Hughes, Rebecca K.
    Joshi, Abhishek
    Cooper, Jackie
    Breitenstein, Alexander
    Ginks, Matthew
    Petersen, Steffen E.
    Mohiddin, Saidi A.
    Dhinoja, Mehul B.
    [J]. THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2022, 16
  • [3] Left ventricular pacing for gradient reduction and symptomatic relief in mid-cavity obstructive hypertrophic cardiomyopathy
    Malcolmson, J. W.
    Joshi, A.
    Ginks, M.
    Petersen, S.
    Mohiddin, S. A.
    Dhinoja, M.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 728 - 729
  • [4] Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy
    Qintar, Mohammed
    Morad, Abdulrahman
    Alhawasli, Hazem
    Shorbaji, Khaled
    Firwana, Belal
    Essali, Adib
    Kadro, Waleed
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (05):
  • [5] Cardiac magnetic resonance imaging predictors of ventricular arrhythmia in mid-cavity obstructive hypertrophic cardiomyopathy
    Malcolmson, J. W.
    Hughes, R. K.
    Shiwani, H.
    Husselbury, T.
    Procter, W.
    Godec, T.
    Davies, R.
    Omahony, C.
    Moon, J.
    Dhinoja, M. B.
    Petersen, S. E.
    Mohiddin, S. A.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 257 - 257
  • [6] Assessment of dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M-PATHY)
    Maron, BJ
    Nishimura, RA
    McKenna, WJ
    Rakowski, H
    Josephson, ME
    Kieval, RS
    [J]. CIRCULATION, 1998, 98 (17) : 506 - 506
  • [7] Preventing Cardiomyopathy in DMD A Randomized Placebo-Controlled Drug Trial
    Bourke, John P.
    Watson, Gillian
    Spinty, Stefan
    Bryant, Andrew
    Roper, Helen
    Chadwick, Thomas
    Wood, Ruth
    McColl, Elaine
    Bushby, Kate
    Muntoni, Francesco
    Guglieri, Michela
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (05) : E661 - E668
  • [8] Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy - A randomized, double-blind, crossover study (M-PATHY)
    Maron, BJ
    Nishimura, RA
    McKenna, WJ
    Rakowski, H
    Josephson, ME
    Kieval, RS
    [J]. CIRCULATION, 1999, 99 (22) : 2927 - 2933
  • [9] Dual-chamber pacing in hypertrophic obstructive cardiomyopathy with biventricular outflow tract obstruction and severe drug-refractory symptoms in a 9-year-old girl
    Ohtani, K
    Satoh, A
    Eto, S
    Satoh, T
    Ichinose, K
    Satoh, S
    Takahashi, T
    Koda, M
    Kinjo, M
    Yonesaka, S
    [J]. PEDIATRICS INTERNATIONAL, 2003, 45 (06) : 743 - 746
  • [10] Clinical effects of metoprolol in obstructive hypertrophic cardiomyopathy (TEMPO). A randomized, double-blinded, placebo-controlled crossover trial
    Dybro, A. M.
    Rasmussen, T. B.
    Nielsen, R. R.
    Andersen, M. J.
    Jensen, M. K.
    Poulsen, S. H.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1769 - 1769
1234